EURICAN PIRO
EURICAN PIRO
Not authorised
- Babesia canis, soluble parasite antigen, Inactivated
Product identification
Medicine name:
EURICAN PIRO
Active substance:
- Babesia canis, soluble parasite antigen, Inactivated
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Babesia canis, soluble parasite antigen, Inactivated2.20/log10 immunofluorescence unit(s)1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AO
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Revoked
Authorised in:
-
Italy
Package description:
- Available only in Italian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Italian (PDF)
Published on: 3/06/2022
How useful was this page?:
